Interim analysis of a phase II trial of 5-azacitidine (5AC) and entinostat (SNDX-275) in relapsed advanced lung cancer (NSCLC) Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Juergens, Rosalyn
  • Vendetti, F
  • Coleman, B
  • Sebree, RS
  • Rudek, MA
  • Belinsky, S
  • Brock, M
  • Herman, J
  • Baylin, S
  • Rudin, CM

publication date

  • May 20, 2009